ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: FR-PO1021

Developing City-Level Nephrology Indicators Using Open Data

Session Information

Category: Diversity and Equity in Kidney Health

  • 900 Diversity and Equity in Kidney Health

Authors

  • Cojuc, Gabriel, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Ciudad de Mexico, Ciudad de México, Mexico
  • Braverman-Poyastro, Alan, Red de Universidades Anahuac, Naucalpan de Juarez, Mexico, Mexico
  • De Las Fuentes, Alejandra, Hospital Universitario Dr Jose Eleuterio Gonzalez, Monterrey, Nuevo León, Mexico
  • Mizrahi Drijanski, Andrea, Red de Universidades Anahuac, Naucalpan de Juarez, Mexico, Mexico
  • Rodriguez-Paniagua, Briana, Universidad Panamericana, Ciudad de Mexico, Ciudad de México, Mexico
  • Nordmann-Gomes, Alberto, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Ciudad de Mexico, Ciudad de México, Mexico
  • Moscona-Nissan, Alberto, Universidad Panamericana, Ciudad de Mexico, Ciudad de México, Mexico
  • Guijosa, Alberto, Universidad Panamericana, Ciudad de Mexico, Ciudad de México, Mexico
  • Canaviri, Vianca Anabel, Hospital Obrero No 1, La Paz, La Paz, Bolivia, Plurinational State of
  • Tinajero Sánchez, Denisse Nayely, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Ciudad de Mexico, Ciudad de México, Mexico
  • Chopra, Bhavna, Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
  • Correa-Rotter, Ricardo, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Ciudad de Mexico, Ciudad de México, Mexico
  • Ramirez-Sandoval, Juan Carlos, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Ciudad de Mexico, Ciudad de México, Mexico
Background

Sustainable Development Goal 11—sustainable cities and communities— holds the potential to improve kidney health by enhancing access to CKD care. Most nephrology indicators overlook local heterogeneity. We aimed to develop novel city-level nephrology indicators.

Methods

We obtained data from open sources (Global Burden of Disease, WHO, ISN-GKHA, Global Observatory of Healthy and Sustainable Cities [GOHSC]) and from our systematic review of pharmacologic CKD randomized controlled trials (RCTs). We selected 214 RCTs with GOHSC participant cities. We calculated the following indicators: CKD-prevalence-adjusted (per 100,000 with CKD) RCT sites [95% CI], nephrologists, and dialysis centers; RCT sites and dialysis centers per km2, RCTs/nephrologist, and CKD stage 5 RCTs per dialysis center.

Results

Among GOHSC, Lisbon had the highest number of CKD-prevalence-adjusted RCT sites (14.8 [13.7-16.1]), and Mexico City had the lowest (0.5 [0.5-0.6]). Spanish cities had the highest prevalence-adjusted nephrologists, and United States cities had the highest prevalence-adjusted dialysis centers (51.3 [47.7-55.4] and 33.21 [31.2-35.6], respectively), while Chennai had the lowest (2.1 [2.0-2.3] and 0.6 [0.6-0.6], respectively). Lisbon had the most RCT sites/km2 (0.1), Seattle had the fewest (0.004). Hong Kong had the highest dialysis centers/km2 (0.1), and Hanoi had the lowest (0.006). Odense had the highest RCTs/nephrologist (2.8) and stage 5 CKD RCTs per dialysis center (8.3), and Cologne and Baltimore had the lowest (0.1 and 0.03, respectively).

Conclusion

City-level, standardized nephrology indicators should be developed for policymaking and benchmarking. We provided an initial comprehensive model for further global elaboration.